The Group's principal activity is to discover and develop drugs for the treatment of bacterial infections, fungal infections and skin diseases associated with high unmet medical needs. The Group focuses on antibacterial, antifungal and dermatological markets. The Group operates in Switzerland, China and Other Countries.
Alacra Alerts:
Receive alerts on the latest reports on Basilea Pharmaceutica AG
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
